Bahrain vs Chile: Cause of death, by non-communicable diseases, ages 0-4, male
Bahrain
48.9%
in 2021
Chile
49.4%
in 2021
Bahrain rank
13th
Chile rank
12th
Cause of death, by non-communicable diseases, ages 0-4, male over time
- Bahrain
- Chile
How they compare
Chile currently reports 49.4% against 48.9% in Bahrain, a difference of 0.5%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Bahrain ahead.
Bahrain ranks 13th and Chile ranks 12th of 185 countries.
Across the 3 decades both report, Bahrain averaged higher in 2 and Chile in 1.
Head to head by decade
| Decade | Bahrain | Chile | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 52.9% | 43.0% | 10.0% | Bahrain |
| 2010s | 49.7% | 47.4% | 2.4% | Bahrain |
| 2020s | 48.8% | 49.4% | 0.6% | Chile |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, male, Bahrain or Chile?
- Chile, at 49.4% against 48.9% in Bahrain as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4, male between Bahrain and Chile?
- 0.5%, with Chile ahead.
- How many years of comparable data are there for Bahrain and Chile?
- 6 years are reported by both, from 2000 to 2021.
- How do Bahrain and Chile rank globally for cause of death, by non-communicable diseases, ages 0-4, male?
- Bahrain ranks 13th and Chile ranks 12th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4, male (% of total male deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 0-4 due to non-communicable diseases divided by number of all male deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.